One Year Outcome After Robotic Assisted Laparoscopic Sacral Colpopexy, a Case Series Review

Sponsor
Atlantic Health System (Other)
Overall Status
Completed
CT.gov ID
NCT01055860
Collaborator
(none)
75
1
16.9
4.4

Study Details

Study Description

Brief Summary

Robotic approach to sacral colpopexy is a relatively new procedure. The literature is scarce in regard to its long-term outcomes. This advanced procedure is offered at MMH through the Urogynecology division. The Investigators setup to review the one year outcome of patients who underwent this procedure using a polypropylene mesh. These outcomes will include anatomical and quality of life measures.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    75 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    One Year Outcome After Robotic Assisted Laparoscopic Sacral Colpopexy, a Case Series Review
    Study Start Date :
    Feb 1, 2009
    Actual Primary Completion Date :
    Feb 1, 2010
    Actual Study Completion Date :
    Jul 1, 2010

    Arms and Interventions

    Arm Intervention/Treatment
    Robotic sacral colpopexy

    Our study population will be women who underwent Robotic assisted laparoscopic sacral colpopexy at the Morristown Memorial Hospital for correction of pelvic organ prolapse using a synthetic polypropylene mesh.

    Outcome Measures

    Primary Outcome Measures

    1. 1. Objective anatomic outcomes We will use the pelvic organ prolapse quantification system (POP-Q). Objective surgical failure will be defined as any prolapse at or beyond the introitus [one year]

    Secondary Outcome Measures

    1. 2. Prolapse Specific Quality of Life Patients will complete a prolapse specific quality of life instrument prior to and one year after surgery. (PFIQ-7) [one year]

    2. 3. Pelvic organ prolapse related symptoms (PFDI-20) [one year]

    3. 4. Graft-related complications Rates of graft erosion into adjacent organs such as bowel, bladder or vagina - during the study period will be reported. [one year]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Any Robotic assisted laparoscopic sacral colpopexy with polypropylene mesh during the study period
    Exclusion Criteria:
    • Other graft material than polypropylene.

    • Enrollment in a different study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Atlantic Health Urogynecology Morristown New Jersey United States 07960

    Sponsors and Collaborators

    • Atlantic Health System

    Investigators

    • Principal Investigator: Patrick Culligan, MD, Atlantic Health System

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01055860
    Other Study ID Numbers:
    • R09-02-007
    First Posted:
    Jan 26, 2010
    Last Update Posted:
    Mar 22, 2011
    Last Verified:
    Mar 1, 2011

    Study Results

    No Results Posted as of Mar 22, 2011